申请人:Linders Theodorus Maria Joannes
公开号:US20080096869A1
公开(公告)日:2008-04-24
the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n represents an integer being 1 or 2; R
1
and R
2
each independently represents hydrogen C
1-4
alkyl, NR
9
R
10
, C
1-4
alkyloxy; or R
1
and R
2
taken together with the carbon atom with which they are attached form a C
3-6
cycloalkyl; and where n is 2, either R
1
or R
2
may be absent to form an unsaturated bond; R
3
represents a C
6-12
cycloalkyl, preferably selected from cylo-octanyl and cyclohexyl or R
3
represents a monovalent radical having one of the following formulae
wherein said C
6-12
cycloalkyl or monovalent radical may optionally be substituted with one, or where possible two, three or more substituents selected from the group consisting of C
1-4
alkyl, C
1-4
alkyloxy, halo or hydroxy; Q represents Het
1
or Ar
2
wherein said C
3-8
cycloalkyl, Het
1
or Ar
2
are optionally substituted with one or where possible two or more substituents selected from halo, C
1-4
alkyl, C
1-4
alkyloxy, hydroxy, nitro, NR
5
R
6
, C
1-4
alkyloxy substituted with one or where possible two, three or more substituents each independently selected from hydroxycarbonyl, Het
2
and NR
7
R
8
, and C
1-4
alkyl substituted with one or where possible two or three halo substituents, preferably trifluoromethyl; R
5
and R
6
each independently represent hydrogen, C
1-4
alkyl, or C
1-4
alkyl substituted with phenyl; R
7
and R
8
each independently represent hydrogen or C
1-4
alkyl; R
9
and R
10
each independently represent hydrogen, C
1-4
alkyl or C
1-4
alkyloxycarbonyl; L represents C
1-4
alkyl; Het
1
represents a heterocycle selected from pyridinyl, thiophenyl, or 1,3-benzodioxolyl; Het
2
represents piperidinyl, pyrrolidinyl or morpholinyl; Ar
2
represents phenyl, naphtyl or indenyl.